orphan drug act
Billion Dollar Orphans: Tension Between the Legal Intent and Social Purpose of the Orphan Drug Act
... the Orphan Drug Act to confer a seven-year period of exclusivity to only the first drug approved as an orphan drug (meaning a drug with a new active ingredi- ent or that ...
39
The Orphan Drug Act of 1983 : a case study of issue framing and the failure to effect policy change from 1990-1994
... the Orphan Drug Act has been a tremendous ...the orphan drug was developed to treat these children, they had to spend their entire lives in the protection of an isolation ...first ...
190
Therapies for Inborn Errors of Metabolism: What Has the Orphan Drug Act Delivered?
... developments of most biological prod- ucts approved for IEMs were shep- herded by commercial manufacturers, which have better resources and/or experience to handle the complex is- sues involving biological manufactur- ...
8
Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug act
... an orphan drug development pathway can vary within same disease entity: both tocilizumab and canakinumab are approved for the treat- ment of systemic juvenile idiopathic ...the orphan program with ...
12
What the Orphan Drug Act Has Done Lately for Children With Rare Diseases: A 10-Year Analysis
... an orphan drug designation, a sponsor (eg, an investigator, a company, or an organization) must meet 2 criteria: (1) provide a scienti fi c rationale that a product (P1) can potentially treat or prevent a ...
8
Pressure for drug development in lysosomal storage disorders – a quantitative analysis thirty years beyond the US orphan drug act
... diseases. Drug development in neuronopathic lysosomal storage disorders may be facili- tated through the availability of better instruments assessing neurological and behavioral functions in a standardized way as ...
9
Do investors value the FDA orphan drug designation?
... The orphan drug designation was created in 1983 when the Orphan Drug Act (ODA) was enacted by Congress, and is administered by the Office of Orphan Products Development at the ...
6
Challenges in orphan drug development and regulatory policy in China
... and Drug Administration (US FDA) regulatory process for rare disease clinical trials is necessary for developing regulatory policy in ...the Orphan Drug Act of 1983, and has since approved the ...
8
AN INSIGHT ON ORPHAN DRUG DEVELOPMENT STRATEGY IN US AND EUROPE
... for orphan disease causes psychological distress to the patient and the family also, and a feeling of ...of orphan drugs. The Orphan Drug Act (ODA) was came in to force on January 28, ...
6
Incentives for orphan drug research and development in the United States
... the Orphan Drug Act (ODA) went into effect to encourage the development and marketing of drugs (orphan drugs) to treat rare diseases and condi- ...This Act evolved in response to the ...
7
Creation and Development of the Public Service Orphan Drug Human Botulism Immune Globulin
... service orphan drug Human Botulism Immune Globulin for the treat- ment of infant botulism would not have come into existence without the federal Orphan Drug Act and the funding ...
7
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
... FDA orphan drug credits and its’ ef- fect on the out-of-pocket cost born by pharmaceutical com- ...for orphan drugs can be credited to the company, the estimated costs for orphan drugs ...
10
Orphan versus non orphan IPOs: the difference analyst coverage makes
... between orphan and non-orphan IPOs appear in the first year following the ...that orphan IPOs exhibit higher returns than non-orphan IPOs in the first year after their ...
31
Annual Notification of Drug and Alcohol Policies Drug-Free Schools and Communities Act
... From time to time during the academic year, the college may sponsor workshops or seminars and may dis- tribute informational materials dealing with the dangers of drug abuse. Employees are encouraged to attend ...
14
An Update on the Therapeutic Orphan
... OTC drug by raising the age disclaimer, or that additional information may have been collected after the switch, thereby raising the disclaimer ...prescription drug age exclusions, the OTC drug age ...
8
Profiling the orphan enzymes
... local orphan enzymes at the superkingdom level was then estimated (Figure 6; the lists of local orphan and not observed EC numbers are available in Additional file 2: Tables ...of orphan enzymes is ...
16
Examining Why the Canadian Federal Government Placed an Orphan Drug Strategy on Their Decision Agenda Now
... concerning orphan drugs is cost, which has a two-fold ...that orphan drugs fail to be deemed cost- effective by many jurisdictions or private insurance schemes, results in no public insurance coverage and ...
11
Drug-Free Schools & Campuses Act Notification
... While the University will hold students accountable for violations of the alcohol and other drug policies noted below, it is also committed to supporting any student who makes the responsible decision to address ...
21
Policy. Drug- Free School and Communities Act
... a Drug Conviction – Any MACU employee who is convicted under a criminal drug statue for a violation occurring in the workplace must notify the university with in five (5) working days of the ...
8
Orphan Drug Programs, Public-Private Partnerships and Current Efforts to Develop Treatments for Diseases of Poverty
... report to serve as a surrogate for regulatory review in Australia. While the FDA makes its evaluation reports available to the public, it redacts them to avoid d[r] ...
33